Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serafin Gonzalez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Ophthalmology|January 15, 2013
Reply: To PMID 22264942Serafin Gonzalez, Philip J Rosenfeld
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 8, 2007
Maintenance of sterility in 1-mL polypropylene syringesSerafin Gonzalez, Darlene Miller, Steven P Murphy
Optometry (St. Louis, Mo.)|November 1, 2002
A cost analysis of the prostaglandin analogsAndrew B Mick, Serafin Gonzalez, Mark T Dunbar, et al.
Ophthalmology|March 5, 2013
Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative resultsRoger A Goldberg, Harry W Flynn, Darlene Miller, et al.
American Journal of Ophthalmology|January 24, 2012
Avastin doesn't blind people, people blind peopleSerafin Gonzalez, Philip J Rosenfeld, Michael W Stewart, et al.
Retina (Philadelphia, Pa.)|November 30, 2012
Re: Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillanceMichael W Stewart, Serafin Gonzalez, Philip J Rosenfeld, et al.
American Journal of Ophthalmology|January 24, 2012
An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumabRoger A Goldberg, Harry W Flynn, Ryan F Isom, et al.
Retina (Philadelphia, Pa.)|June 14, 2006
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRyan M Rich, Philip J Rosenfeld, Carmen A Puliafito, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Ophthalmology|January 15, 2013
Reply: To PMID 22264942Serafin Gonzalez, Philip J Rosenfeld
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 8, 2007
Maintenance of sterility in 1-mL polypropylene syringesSerafin Gonzalez, Darlene Miller, Steven P Murphy
Optometry (St. Louis, Mo.)|November 1, 2002
A cost analysis of the prostaglandin analogsAndrew B Mick, Serafin Gonzalez, Mark T Dunbar, et al.
Ophthalmology|March 5, 2013
Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative resultsRoger A Goldberg, Harry W Flynn, Darlene Miller, et al.
American Journal of Ophthalmology|January 24, 2012
Avastin doesn't blind people, people blind peopleSerafin Gonzalez, Philip J Rosenfeld, Michael W Stewart, et al.
Retina (Philadelphia, Pa.)|November 30, 2012
Re: Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillanceMichael W Stewart, Serafin Gonzalez, Philip J Rosenfeld, et al.
American Journal of Ophthalmology|January 24, 2012
An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumabRoger A Goldberg, Harry W Flynn, Ryan F Isom, et al.
Retina (Philadelphia, Pa.)|June 14, 2006
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRyan M Rich, Philip J Rosenfeld, Carmen A Puliafito, et al.
Pageof 1